Safety and efficacy of P2X3 receptor antagonist for the treatment of refractory or unexplained chronic cough: A systematic review and meta-analysis of 11 randomized controlled trials

医学 慢性咳嗽 安慰剂 食欲不振 荟萃分析 随机对照试验 内科学 不利影响 敌手 耐火材料(行星科学) 麻醉 哮喘 替代医学 受体 病理 物理 天体生物学
作者
Alaa Ramadan,Mohamed El‐Samahy,Amr Elrosasy,Mohammed Al‐Tawil,Ahmed Abdelaziz,Mostafa A Soliman,Mohamed Abouzid
出处
期刊:Pulmonary Pharmacology & Therapeutics [Elsevier BV]
卷期号:83: 102252-102252 被引量:2
标识
DOI:10.1016/j.pupt.2023.102252
摘要

Chronic refractory cough is a challenging condition that requires a thorough evaluation and management approach. P2X3 receptors that are ATP-dependent play an important part in nerve fiber sensitization and pathological pain pathways. We conducted this systematic review and meta-analysis to determine the long-term safety and efficacy of P2X3 receptor antagonist drugs in chronic cough. We systematically searched PubMed, Scopus, Web of Science, and Embase to identify all relevant published studies through January 15, 2023 that assessed P2X3 antagonists in chronic cough. The protocol was registered in the PROSPERO database with ID: CRD42023422408. Efficacy outcomes were awake (daytime) cough frequency, night cough frequency, 24-h cough frequency, Cough Severity Diary, and total Leicester Cough Questionnaire score. We used the random-effect model to pool the data using RStudio and CMA software. A total of 11 randomized controlled trials comprising 1350 patients receiving a p2x3 antagonist compared to the placebo group were included in this meta-analysis. A significant decrease in 24-h cough frequency (MD = −4.99, 95% CI [−7.15 to −2.82], P < 0.01), awake (daytime) cough frequency (MD = −7.18, 95% CI [−9.98 to 4.37], P < 0.01), and total Leicester Cough Questionnaire score (MD = 1.74, 95% CI [1.02 to 2.46], P < 0.01) exhibited between the P2X3 antagonist and placebo groups. The frequency of the night cough showed an insignificant difference between the two groups. According to the safety, drug-related adverse events, dysgeusia, hypogeusia, and ageusia significantly increased between the P2X3 antagonist and placebo groups. P2X3 receptor antagonists are promising drugs for treating chronic cough by significantly reducing the frequency, severity, and quality. Some potential side effects may include drug-related adverse events such as hypogeusia, ageusia, and dysgeusia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
胡图图完成签到,获得积分10
1秒前
睡觉大王完成签到 ,获得积分10
2秒前
3秒前
3秒前
4秒前
4秒前
9秒前
玩命的十三完成签到 ,获得积分10
9秒前
寂寞的诗云完成签到,获得积分10
11秒前
我爱科研完成签到 ,获得积分10
11秒前
12秒前
Bin_Liu发布了新的文献求助10
13秒前
She完成签到,获得积分10
13秒前
16秒前
Raki完成签到,获得积分10
17秒前
22完成签到 ,获得积分10
17秒前
Echo_1995完成签到,获得积分10
20秒前
徐慕源完成签到,获得积分10
20秒前
able发布了新的文献求助10
21秒前
呜呜完成签到 ,获得积分10
22秒前
22秒前
CQ完成签到 ,获得积分10
23秒前
漂亮天真完成签到,获得积分10
24秒前
gmc完成签到 ,获得积分10
24秒前
怡然白竹完成签到 ,获得积分10
26秒前
懵懂的海露完成签到,获得积分10
30秒前
testz完成签到,获得积分10
32秒前
33秒前
一一一完成签到,获得积分10
36秒前
翊然甜周完成签到,获得积分10
36秒前
36秒前
zdnn完成签到,获得积分10
38秒前
TLDX发布了新的文献求助10
41秒前
鳄鱼蛋完成签到,获得积分10
42秒前
luwenxuan完成签到,获得积分10
42秒前
42秒前
奋斗跳跳糖完成签到,获得积分10
42秒前
小白加油完成签到 ,获得积分10
43秒前
43秒前
星辰大海应助大橙子采纳,获得10
43秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038184
求助须知:如何正确求助?哪些是违规求助? 3575908
关于积分的说明 11373872
捐赠科研通 3305715
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022